Abstract
Unconjugated bilirubin increasingly binds to erythrocytes as the bilirubin-to-albumin molar ratio exceeds unity, leading to toxic manifestations that can culminate in cell lysis. Our previous studies showed that bilirubin induces the release of lipids from erythrocyte membranes. In the present work, those studies were extended in order to characterize the alterations of membrane lipid composition and evaluate whether bilirubin leads to a loss of phospholipid asymmetry. To this end, human erythrocytes were incubated with several bilirubin-to-albumin molar ratios (0.5 to 5), and cholesterol as well as the total and the individual classes of phospholipids were determined. To detect erythrocytes with phosphatidylserine at the outer surface, the number of annexin V-positive cells was determined following incubation with bilirubin, fixing its molar ratio to albumin at 3. The results demonstrate profound changes in erythrocyte membrane composition, including modified cholesterol and phospholipid content. The release of membrane cholesterol, as well as of total and individual classes of phospholipids at molar ratios ≥1, indicates that damage of erythrocytes may occur in severely ill jaundiced neonates. The loss of the inner-located phospholipids, phosphatidylethanolamine and phosphatidylserine, points to a redistribution of phospholipids in the membrane bilayer. This was confirmed by the exposure of phosphatidylserine at the outer cell surface. In conclusion, this study demonstrates that bilirubin induces loss of membrane lipids and externalization of phosphatidylserine in human erythrocytes. These features may facilitate hemolysis and erythrophagocytosis, thus contributing to enhanced bilirubin production and anemia during severe neonatal hyperbilirubinemia.
Similar content being viewed by others
References
Ahifors CE. Criteria for exchange transfusion in jaundiced newborns. Pediatrics. 1994:93:488–94.
Baldwin JM, O'Reilly R, Whitney M, Lucy JA. Surface exposure of phosphatidylserine is associated with the swelling and osmotically-induced fusion of human erythrocytes in the presence Of a2+. Biochim Biophys Acta. 1990:1028: 14–20.
Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 1959:234:466–8.
Belanger S, Lavoie JC, Chessex P. Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. Biol Neonate. 1997:71:233–8.
Boas FE, Forman L, Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Nati Acad Sci USA. 1998:95:3077–81.
Bonillo-Perales A, Munoz-Hoyos A, Martinez-Morales A, Molina-Carballo A, Uberos-Fernandez J, Puertas-Prieto A. Changes in erythrocytic deformability and plasma visc-osity in neonatal ictericia. Am J Perinatol. 1999:16:421–7.
Bonomini M, Sirolli V, Settefrati N, Dottori S, Di Liberate L, Arduini A. Increased erythrocyte phosphatidylserine expo-sure in chronic renal failure. J Am Soc Nephrol. 1999:10: 1982–90.
Bratlid D. Bilirubin binding by human erythrocytes. Scand J Clin Lab Invest. 1972:29:91–7.
Brites D, Silva R, Brito A. Effect of bilirubin on erythrocyte shape and haemolysis, under hypotonic, aggregating or non-aggregating conditions, and correlation with cell age. Scand J Clin Lab Invest. 1997:57:337–50.
Brito MA. InteracCBo da bilirrubina corn o eritrocito. Especies moleculares envolvidas, estadios de toxicidade e comporta-mento da celula fetal. PhD thesis. University of Lisbon; 2001.
Brito MA, Silva RM, Matos DC, da Silva AT, Brites DT. Alterations of erythrocyte morphology and lipid composi-tion by hyperbilirubinemia. Clin Chim Acta. 1996:249:149–65.
Brito MA, Silva R, Tiribelli C, Brites D. Assessment of bilirubin toxicity to erythrocytes. Implication in neonatal jaundice management. Eur J Clin Invest. 2000:30:239–47.
Brito MA, Brondino CD, Moura JJG, Brites D. Effects of bilirubin molecular species on membrane dynamic proper-ties of human erythrocyte membranes: A spin label electron paramagnetic resonance spectroscopy study. Arch Biochem Biophys. 2001:387:57–65.
Brodersen R. Binding of bilirubin to albumin. CRC Crit Rev ClinLabSci. 1980:11:305–401.
Brodersen R, Stern L. Deposition of bilirubin acid in the central nervous system-a hypothesis for the development ofkernicterus. Acta Paediatr Scand. 1990:79:12–9.
Butikofer P, Lin ZW, Chiu DT, Lubin B, Kuypers FA. Transbi-layer distribution and mobility ofphosphoinositol in human red blood cells. J Biol Chem. 1990:265:16035–8.
Cashore WJ. Free bilirubin concentrations and bilirubin-bind-ing affinity in term and preterm infants. J Pediatr. 1980:96: 521–7.
Cheung WH, Sawitsky A, lsenberg HD. The effect of bilirubin on the mammalian erythrocyte. Transfusion. 1966:6:475–6.
Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts. Arch BiochemBiophys. 1963:100:119–29.
Eriksen EF, Danielsen H, Brodersen R. Bilirubin-liposome interaction. Binding of bilirubin dianion, protonization, and aggregation of bilirubin acid. J Biol Chem. 1981;256: 4269–74.
Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 1998:5:551–62.
Fadok VA, de Cathelineau A, Daleke DL, Henson PM, Bratton DL. Loss ofphospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apop-totic cells by macrophages and fibroblasts. J Biol Chem. 2001:276:1071–7.
Gascard P, Tran D, Sauvage M, et al. Asymmetric distribution of phosphoinositides and phosphatidic acid in the human erythrocyte membrane. Biochim Biophys Acta. 1991:1069: 27–36.
Glushko V, Thaler M, Ross M. The fluorescence of bilirubin upon interaction with human erythrocyte ghosts. Biochim Biophys Acta. 1982; 719:65–73.
Gourley GR. Bilirubin metabolism and kernicterus. Adv Pediatr. 1997:44:173–229.
Greenwalt TJ, Dumaswala UJ. Effect of red cell age on vesiculation 171 vitro. Br J Haematol. 1988:68:465–7.
Greenwalt TJ, Bryan DJ, Dumaswala UJ. Erythrocyte mem-brane vesiculation and changes in membrane composition during storage in citrate-phosphate-dextrose-adenine-I. Vox Sang. 1984:47:261–70.
Hagerstrand H, Holmstrom TH, Bobrowska-Hagerstrand M, Eriksson JE, Isornaa B. Amphiphile-induced phosphatidyl-serine exposure in human erythrocytes. Mol Membr Biol. 1998:15:89–95.
Hansen TWR. Acute management of extreme neonatal jaundice-the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr. 1997:86:843–6.
Hansen TWR. Neonatal hyperbilirubinemia and kernicterus. A 1998 update. J Med Liban. 1999:47:22–7.
Johnston MV, Hoon AH. Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol. 2000; 15:588–91.
Kaneko K, Takei Y, Aoki T, Ikeda S, Matsunami H, Lynch S.Bilirubin adsorption therapy and subsequent liver trans-plantation cured severe bilirubin encephalopathy in a long-term survival patient with Crigler-Najjar disease type 1. Intern Med. 2000:39:871–2.
Kaul R, Bajpai VK, Shipstone AC, Kaul HK, Krishna Murti CR. Bilirubin-induced erythrocyte membrane cytotoxicity. ExpMolPathol. 1981:34:290–8.
Kirschner-Zilber I, Rabizadeh E, Shaklai N. The interaction of hemin and bilirubin with human red cell membrane. Biochim Biophys Acta. 1982:690:20–30.
Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection ofphosphatidylserine expression on B cells under-going apoptosis. Blood. 1994:84:1415–20.
Kuypers FA, Lewis RA, Hua M, et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood. 1996;87:1179–87.
Kuypers FA, Yuan J, Lewis RA, et al. Membrane phospholipid asymmetry in human thalassemia. Blood. 1998:91:3044–51.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem. 1951:193:265–75.
Luly P. Membrane lipid changes in the abnormal red cell. In: Raess BU, Tunnicliff G, eds. The red cell membrane. New Jersey: Clifton; 1989:399–21.
Mazurnder S, Sarkar U, Sengupta D. Biochemical profile of erythrocyte membrane of jaundiced neonates. Indian J Exp Biol. 2000:38:91–4.
McDonagh AF, Assisi F. The ready isomerization of bilirubin IX-Ot in aqueous solution. Biochem J. 1972:129:797–800.
McEvoy L, Williamson P, Schlegel RA. Membrane phospholi-pid asymmetry as a determinant of erythrocyte recognition byrnacrophages. ProeNatlAcad Sci USA. 1986:83:3311–5.
Mireles LC, Lum MA, Dennery PA. Antioxidant and cytotoxic effects of bilirubin on neonatal erythrocytes. Pediatr Res. 1999:45:355–62.
Mustafa MG, King TE. Binding of bilirubin with lipid. A possible mechanism of its toxic reactions in mitochondria. J Biol Chem. 1970:245:1084–9.
Nagaoka S, Cowger ML. Interaction of bilirubin with lipids studied by fluorescence quenching method. J Biol Chem. 1978:253:2005–11.
Odell GB. Neonatal hyperbilirubinemia. New York: Greene & Stratton, Inc; 1980:35–49.
Periman JM, Rogers BB, Burns D. Kernicteric findings at autopsy in two sick near term infants. Pediatrics. 1997:99: 612–5.
Rashid H, Ali MK, Tayyab S. Differential accessibility of bilirubin to erythrocyte membrane vesicles bearing different structural features. Comp Biochem Physiol Pharmacol Toxicol Endocrinol. 2000:127:345–50.
Rettig MP, Low PS, Gimm A, Mohandas N, Wang J, Christian JA. Evaluation of biochemical changes during in vivo ery-throcyte senescence in the dog. Blood. 1999:93: 376–84.
Rimon G, Bazenet CE, Philpott KL, Rubin LL. Increased surface phosphatidylserine is an early marker of neuronal apoptosis. JNeurosciRes. 1997:48:563–70.
Rodrigues CMP, Sola S, Brito MA, Brites D, Moura JJG. Bilirubin directly disrupts membrane lipid polarity and fluidity, protein order, and redox status in rat mitochondria. J Hepatol 2002:36:335–41.
Rouser G, Fleischer S, Yamamoto A. Two dimensional thin layer chromatographic separation of polar lipids and deter-mination ofphospholipids by phosphorus analysis of spots. Lipids. 1969:5:494–6.
Sato H, Aono S, Semba R, Kashiwamata S. Interaction of bilirubin with human erythrocyte membranes. Bilirubin binding to neuraminidase-and phospholipase-treated membranes. Biochem J. 1987:248:21–6.
Schewe M, Muller P, Korte T, Herrmann A. The role of phospholipid asymmetry in calcium-phosphate-induced fu-sion of human erythrocytes. J Biol Chem. 1992:267:5910–5.
Schroit AJ, Madsen JW, Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem. 1985:260:5131–8.
Schutte B, Nuydens R, Geerts H, Ramaekers F. Annexin V binding assay as a tool to measure apoptosis in differen-tiated neuronal cells. J Neurosci Methods. 1998:86:63–9.
Sharma R, Premachandra BR. Membrane-bound hemoglobin as a marker of oxidative injury in adult and neonatal red blood cells. Biochem Med Metab Biol. 1991:46:33–44.
Silva R, Rodrigues CMP, Brites D. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxy-cholic acid but prevented by ursodeoxycholic acid. J Hepatol. 2001:34:402–8.
Tayyab S, Ali MK. Binding of bilirubin to mammalian erythrocytes. Comp Biochem Physiol. 1997;118B:97–103.
Vazquez J, Garcia-Calvo M, Valdivieso F, Mayor F, Mayor F Jr. Interaction of bilirubin with the synaptosomal plasma membrane. JBiol Chem. 1988:263:1255–65.
Verkleij A, Zwaal R, Roelofsen B, Comfurius P, Kastelijn D, van Deenen L. The asymmetric distribution of phospholi-pids in the human red cell membrane: a combined study using phospholipases and freeze-etch electron microscopy. Biochim Biophys Acta. 1973:323:178–93.
Vitiello F, Zanetta J-P. Thin-layer chromatography ofphospho-lipids. JChromatogr. 1978:166:637–0.
Zackowski A. Phospholipids in animal eukariotic membranes: transverse asymmetry and movement. Biochem J. 1993:294: 1–14.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brito, M., Silva, R. & Brites, D. Bilirubin induces loss of membrane lipids and exposure of phosphatidylserine in human erythrocytes. Cell Biol Toxicol 18, 181–192 (2002). https://doi.org/10.1023/A:1015563704551
Issue Date:
DOI: https://doi.org/10.1023/A:1015563704551